Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Nephrology

Long-Term Monitoring and Protecting Your Kidneys

At a Glance

Chronic pyelonephritis can cause silent high blood pressure, protein in the urine, and declining kidney function because of renal scarring. Regular blood pressure, urine ACR, and eGFR checks plus individualized treatment help protect the kidneys over time.

While the immediate focus of chronic pyelonephritis (CPN) is often on clearing infections, the long-term goal is managing the “silent” effects of renal scarring. Permanent scars do not just represent past damage; they can change how the kidney functions and how the body regulates blood pressure. With careful monitoring and proactive management, many people with renal scars live healthy lives and avoid major complications [1][2].

The Long-Term Risks of Renal Scarring

When a portion of the kidney is replaced by scar tissue, the remaining healthy parts of the kidney have to work harder. This process can lead to three primary long-term concerns:

  • Hypertension (High Blood Pressure): This is one of the most common complications of renal scarring [3]. It happens because scarred areas often have poor blood flow. The kidney senses this as “low pressure” and releases a hormone called renin [4]. Renin triggers a chain reaction (the RAAS system) that causes the body to hold onto salt and tighten blood vessels, raising blood pressure throughout the entire body [4][5].
  • Proteinuria (Protein in the Urine): As the healthy parts of the kidney “overwork” to make up for the scarred areas, the kidney’s filters can become stressed and begin to leak protein (albumin) into the urine [6][7]. This is often measured as the albumin-to-creatinine ratio (ACR) [8].
  • Chronic Kidney Disease (CKD): If scarring is extensive or affects both kidneys, the total filtering capacity of the kidneys may gradually decline over decades [3][9]. CKD is defined as a kidney-structure or kidney-function abnormality persisting for more than three months. This function is estimated by the eGFR (estimated glomerular filtration rate), which is calculated from blood tests (like creatinine) rather than measured directly [10].

A Framework for Individualized Monitoring

Because kidney damage and high blood pressure often have no symptoms, regular “check-ups” are the only way to catch complications early. Monitoring is especially important for those with bilateral (both sides) scarring or high-grade reflux [11][3]. The exact frequency of testing should be individualized by your clinician based on your specific risks.

Test What it Measures Why it Matters
Blood Pressure The force of blood against artery walls. Scars can cause “silent” hypertension. Some doctors recommend Ambulatory Blood Pressure Monitoring (ABPM)—a 24-hour wearable monitor—because office readings can miss high pressure that happens only at night [12][13].
Urine ACR The amount of albumin (protein) leaking into urine. This is often the earliest sign that a kidney is under stress and needs more protection [8][14]. Note: ACR can be temporarily elevated during a fever, UTI, exercise, or menstruation; abnormal results usually need to be confirmed after recovery.
eGFR (Blood Test) An estimate of the speed at which the kidneys filter waste. This tracks the overall “stage” of kidney function and helps guide long-term prognosis [10][9].

Strategies to Protect Kidney Function

Protecting the kidneys involves both medical intervention and daily lifestyle choices designed to reduce the “workload” on the remaining healthy tissue.

Medical Interventions and Safety

If hypertension or significant proteinuria is detected, doctors often prescribe medications known as ACE inhibitors (like lisinopril) or ARBs (like losartan) [15]. These drugs specifically target the renin system that scarred kidneys tend to over-activate. They help lower blood pressure and reduce the amount of protein leaking through the filters, which can slow the progression of CKD [16][17].

  • Safety Warning: ACE inhibitors and ARBs require regular clinician monitoring of your blood creatinine and potassium levels.
  • Pregnancy Warning: These medications are generally contraindicated (unsafe) in pregnancy. If you are planning a pregnancy, contact your clinician promptly to adjust your medications before conception. Do not start, stop, or combine these medicines without medical advice.

Lifestyle and Safety

  • Sodium (Salt) Restriction: Reducing salt in the diet helps lower blood pressure and makes kidney-protective medications work more effectively [16][18].
  • Avoid Nephrotoxins: Certain medications can be “toxic” to kidneys that are already working hard. You should be cautious with NSAIDs (like ibuprofen or naproxen). The risk is highest if you have reduced kidney function, are dehydrated, or if you take an ACE inhibitor/ARB plus a diuretic. Check with your pharmacist or doctor before taking new medications [19][20].
  • Healthy Weight and Exercise: Maintaining a healthy weight and staying active helps control blood pressure and reduces the metabolic stress on the kidneys [16][21].

What is the Outlook?

The prognosis for CPN varies widely based on how much scarring is present. While some children with severe, bilateral damage may progress to CKD earlier in life, many individuals with focal scars from childhood VUR maintain stable kidney function well into adulthood [2][9]. The key to a positive outlook is consistent, individualized follow-up to ensure that any “silent” changes in blood pressure or protein are managed before they cause further damage [9][22]. Referrals to a specialist (nephrologist or urologist) are often appropriate when abnormalities persist or are bilateral.

Common questions in this guide

Which tests monitor kidney health after chronic pyelonephritis?
Regular blood pressure checks, urine albumin-to-creatinine ratio testing, and eGFR blood tests help detect changes that may not cause symptoms. Some people may also need 24-hour ambulatory blood pressure monitoring, and the testing schedule should be based on the extent of scarring, reflux, and kidney function.
Can kidney scarring from chronic pyelonephritis cause high blood pressure?
Yes. Scarred areas may disrupt the kidney signals that help control blood pressure, so hypertension can develop without noticeable symptoms. Finding and treating high blood pressure early can help protect the remaining kidney tissue.
Are ACE inhibitors or ARBs used to protect kidneys with chronic pyelonephritis?
If high blood pressure or significant protein in the urine is present, a clinician may prescribe an ACE inhibitor or an angiotensin receptor blocker. These medicines can lower blood pressure and reduce protein leakage, but creatinine and potassium need regular monitoring, and these medicines are generally unsafe during pregnancy.
Which pain relievers can harm kidneys with chronic pyelonephritis?
NSAIDs, including ibuprofen and naproxen, can strain or injure the kidneys, especially when kidney function is reduced or you are dehydrated. Ask a clinician or pharmacist before taking a new over-the-counter medicine, particularly if you use an ACE inhibitor, ARB, or diuretic.
What is the long-term outlook for chronic pyelonephritis?
The outlook depends on how much scarring is present and whether one or both kidneys are affected. Some people with limited scars remain stable for many years, while severe bilateral damage can increase the risk of chronic kidney disease earlier in life; individualized follow-up helps identify changes promptly.
When should someone with chronic pyelonephritis see a nephrologist?
Referral may be appropriate when blood pressure or urine protein remains abnormal, eGFR declines, or scarring is extensive or affects both kidneys. Your treating clinician can determine when specialist input is needed based on trends in your results and your overall risk.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How extensive is the scarring on my (or my child's) latest DMSA scan, and is it in one kidney or both?
  2. 2.Is my current blood pressure within the target range for my level of kidney function, and should we consider a 24-hour ambulatory monitor to check for 'silent' high blood pressure at night?
  3. 3.What is my current albumin-to-creatinine ratio (ACR), and does the amount of protein in my urine suggest we should start a medication like an ACE inhibitor?
  4. 4.How often do you recommend we check my eGFR (kidney function) to monitor for long-term changes?
  5. 5.Are there any specific medications, like certain over-the-counter pain relievers, that I must avoid to protect my kidneys?
  6. 6.At what point in my eGFR or protein trends should I be referred to a specialist nephrologist?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Insignificant impact of VUR on the progression of CKD in children with CAKUT.

    Ishikura K, Uemura O, Hamasaki Y, et al.

    Pediatric nephrology (Berlin, Germany) 2016; (31(1)):105-12 doi:10.1007/s00467-015-3196-1.

    PMID: 26404649
  2. 2

    Long-term consequences of urinary tract infection in childhood: an electronic population-based cohort study in Welsh primary and secondary care.

    Hughes K, Cannings-John R, Jones H, et al.

    The British journal of general practice : the journal of the Royal College of General Practitioners 2024; (74(743)):e371-e378 doi:10.3399/BJGP.2023.0174.

    PMID: 38806210
  3. 3

    The long-term prognosis of nephropathy in operated reflux.

    Matsuoka H, Tanaka M, Yamaguchi T, et al.

    Journal of pediatric urology 2019; (15(6)):605.e1-605.e8 doi:10.1016/j.jpurol.2019.08.015.

    PMID: 31570232
  4. 4

    A Diagnostic Blind Spot in Pseudo-Bartter Syndrome: Aberrant Renin-angiotensin-aldosterone System Activation from Focal Renal Scarring.

    Makino H, Takedani K, Ishihara SI, et al.

    Internal medicine (Tokyo, Japan) 2026; (65(13)):1786-1793 doi:10.2169/internalmedicine.6414-25.

    PMID: 41224275
  5. 5

    Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.

    Chen L, Yang T, Lu DW, et al.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018; (101()):670-681 doi:10.1016/j.biopha.2018.02.090.

    PMID: 29518614
  6. 6

    Hyperfiltration-mediated Injury in the Remaining Kidney of a Transplant Donor.

    Srivastava T, Hariharan S, Alon US, et al.

    Transplantation 2018; (102(10)):1624-1635 doi:10.1097/TP.0000000000002304.

    PMID: 29847501
  7. 7

    Changing Protein Permeability with Nephron Loss: Evidence for a Human Remnant Nephron Effect.

    Willows J, Odudu A, Logan I, et al.

    American journal of nephrology 2019; (50(2)):152-159 doi:10.1159/000501472.

    PMID: 31269482
  8. 8

    Urinary albumin excretion and chronic kidney disease in children with vesicoureteral reflux.

    de Sépibus R, Cachat F, Meyrat BJ, et al.

    Journal of pediatric urology 2017; (13(6)):592.e1-592.e7 doi:10.1016/j.jpurol.2017.04.004.

    PMID: 28483464
  9. 9

    Predictors of Renal Dysfunction in Adults with Childhood Vesicoureteral Reflux after Long-Term Follow-Up.

    Bundovska-Kocev S, Kuzmanovska D, Selim G, Georgievska-Ismail L

    Open access Macedonian journal of medical sciences 2019; (7(1)):107-113 doi:10.3889/oamjms.2019.078.

    PMID: 30740171
  10. 10

    Laboratory Assessment of Diabetic Kidney Disease.

    Narva AS, Bilous RW

    Diabetes spectrum : a publication of the American Diabetes Association 2015; (28(3)):162-6 doi:10.2337/diaspect.28.3.162.

    PMID: 26300608
  11. 11

    Predictive Factors of Chronic Kidney Disease in Patients with Vesicoureteral Reflux Treated Surgically and Followed after Puberty.

    Kang M, Lee JK, Im YJ, et al.

    The Journal of urology 2016; (195(4 Pt 1)):1100-6.

    PMID: 26555955
  12. 12

    The importance of ambulatory blood pressure monitoring for diagnosing masked hypertension in patients with renal parenchymal scarring.

    Karakaya D, Çakıcı EK, Yazılıtaş F, et al.

    Pediatric nephrology (Berlin, Germany) 2023; (38(4)):1215-1222 doi:10.1007/s00467-022-05754-4.

    PMID: 36156734
  13. 13

    Association between serum cystatin C levels and hypertension in children with kidney scarring.

    Akaci O, Kahraman I

    Pediatric nephrology (Berlin, Germany) 2026; (41(7)):2071-2077 doi:10.1007/s00467-026-07204-x.

    PMID: 41677915
  14. 14

    Albuminuria is associated with 24-hour and night-time diastolic blood pressure in urinary tract infection with renal scarring.

    Baltu D, Salancı BV, Gülhan B, et al.

    The Turkish journal of pediatrics 2023; (65(4)):620-629.

    PMID: 37661677
  15. 15

    Renin angiotensin aldosterone inhibitors in the treatment of proteinuria in children with congenital anomalies of the kidney and urinary tract: more evidence needed.

    Rivetti G, Gizzone P, Di Sessa A, et al.

    Expert review of clinical pharmacology 2023; (16(9)):791-798 doi:10.1080/17512433.2023.2247985.

    PMID: 37577983
  16. 16

    Hypertension in chronic kidney disease-treatment standard 2023.

    Georgianos PI, Agarwal R

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2023; (38(12)):2694-2703 doi:10.1093/ndt/gfad118.

    PMID: 37355779
  17. 17

    AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease.

    Rodríguez-Romo R, Benítez K, Barrera-Chimal J, et al.

    Kidney international 2016; (89(2)):363-73 doi:10.1038/ki.2015.320.

    PMID: 26509589
  18. 18

    Chronic kidney disease.

    Kalantar-Zadeh K, Jafar TH, Nitsch D, et al.

    Lancet (London, England) 2021; (398(10302)):786-802 doi:10.1016/S0140-6736(21)00519-5.

    PMID: 34175022
  19. 19

    Chronic Kidney Disease Diagnosis and Management: A Review.

    Chen TK, Knicely DH, Grams ME

    JAMA 2019; (322(13)):1294-1304 doi:10.1001/jama.2019.14745.

    PMID: 31573641
  20. 20

    Determining risk factors for triple whammy acute kidney injury.

    Leete J, Wang C, López-Hernández FJ, Layton AT

    Mathematical biosciences 2022; (347()):108809 doi:10.1016/j.mbs.2022.108809.

    PMID: 35390421
  21. 21

    Chronic kidney disease as a cardiovascular risk factor.

    Carmena R, Ascaso JF, Redon J

    Journal of hypertension 2020; (38(11)):2110-2121 doi:10.1097/HJH.0000000000002506.

    PMID: 32649622
  22. 22

    Primary Vesicoureteral Reflux and Renal Scarring.

    Mattoo TK, Mohammad D

    Pediatric clinics of North America 2022; (69(6)):1115-1129 doi:10.1016/j.pcl.2022.07.007.

    PMID: 36880925

This page explains long-term monitoring and kidney protection in chronic pyelonephritis for informational purposes only and does not constitute medical advice. Your clinician, nephrologist, or urologist should interpret your results and guide medication changes, especially during pregnancy.

Get notified when new evidence is published on chronic pyelonephritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.